These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Is breast cancer overdiagnosis also nested in pathologic misclassification? Colin C, Devouassoux-Shisheboran M, Sardanelli F. Radiology; 2014 Dec; 273(3):652-5. PubMed ID: 25420166 [No Abstract] [Full Text] [Related]
54. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Sloane JP, Ellman R, Anderson TJ, Brown CL, Coyne J, Dallimore NS, Davies JD, Eakins D, Ellis IO, Elston CW. Eur J Cancer; 1994 Apr; 30A(10):1414-9. PubMed ID: 7833094 [Abstract] [Full Text] [Related]
57. [Variations in the diagnostic confirmation process between breast cancer mass screening units]. Natal C, Fernández-Somoano A, Torá-Rocamora I, Tardón A, Castells X, en nombre del grupo BELE. Gac Sanit; 2016 Apr; 30(4):265-71. PubMed ID: 27137776 [Abstract] [Full Text] [Related]
58. Will ductal carcinoma in situ defeat breast cancer screening? Benson JR. BMJ; 2009 Mar 09; 338():b957. PubMed ID: 19273512 [No Abstract] [Full Text] [Related]